Seaport Therapeutics Inc. Common Stock

SPTX | NASDAQ

$19.39

-$0.21 (-1.07%)

Nov 2, 2026, 2:33 PM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026
PE Ratio	-13.16	-41.33
PEG Ratio	-0.09	n/a
PS Ratio	n/a	n/a
PB Ratio	2.75	-9.10
P/FCF Ratio	-25.10	-52.16
P/OCF Ratio	-25.10	-52.16
OCF/S Ratio	n/a	n/a
Debt / Equity Ratio	0.01	-0.05
Quick Ratio	18	13.24
Current Ratio	18	13.24
Asset Turnover	n/a	n/a
Interest Coverage	n/a	n/a
Return on Equity	-14.81%	21.98%
Return on Assets	-14.17%	-11.16%
Return on Invested Capital	-15.39%	-12.81%
Dividend Yield	n/a	n/a
Payout Ratio	n/a	n/a
FCF Payout Ratio	n/a	n/a
Gross Profit Margin	n/a	n/a
Net Profit Margin	n/a	n/a
Pretax Profit Margin	n/a	n/a
Operating Profit Margin	n/a	n/a
FCF Margin	n/a	n/a
EBITDA Margin	n/a	n/a